PDB18 THE COST-EFFECTIVENESS OF PIOGLITAZONE COMPARED WITH ROSIGLITAZONE-AN ECONOMIC EVALUATION PROJECTING RESULTS FROM A CLINICAL STUDY INTOTHE FUTURE USING AVALID AND RELIABLE ECONOMIC MODEL FROM ATHIRD PARTY PAYER PERSPECTIVE IN THE USA
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64966-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)64966-2/fulltext
Title :
PDB18 THE COST-EFFECTIVENESS OF PIOGLITAZONE COMPARED WITH ROSIGLITAZONE-AN ECONOMIC EVALUATION PROJECTING RESULTS FROM A CLINICAL STUDY INTOTHE FUTURE USING AVALID AND RELIABLE ECONOMIC MODEL FROM ATHIRD PARTY PAYER PERSPECTIVE IN THE USA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64966-2&doi=10.1016/S1098-3015(10)64966-2
First page :
Section Title :
Open access? :
No
Section Order :
126